+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Neuropathic Back Pain Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Neuropathic Back Pain Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Diclofenac Market Report and Forecast 2025-2034 - Product Thumbnail Image

Diclofenac Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Post Surgical Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Post Surgical Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Peripheral Neuropathic Pain Pipeline Analysis Report 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
From
Conventional and Alternative Pain Treatment Markets - Product Thumbnail Image

Conventional and Alternative Pain Treatment Markets

  • Report
  • November 2020
  • 260 Pages
  • Global
From
Non-opioid Pain Treatment: Global Markets to 2024 - Product Thumbnail Image

Non-opioid Pain Treatment: Global Markets to 2024

  • Report
  • December 2019
  • 165 Pages
  • Global
From
Global Market for Pain Management Drugs and Devices - Product Thumbnail Image

Global Market for Pain Management Drugs and Devices

  • Report
  • November 2023
  • 171 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more